Saturday, February 09, 2019 7:04:25 AM
298 Events, found
Between 10/14/2019 and 10/21/2019
504 Million random dice rolls... and voila
10/17 or 10/18 to be more exact :)
I am afraid to touch the min OAS%, it is the only setting. It can be significant. But we should try again with like 55% etc., 30%...
Dataset Total: Population. Current Day: 2106. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24326865. How many times: 4000
Dataset Total: Population. Current Day: 2107. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24299329. How many times: 4000
Dataset Total: Population. Current Day: 2108. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24318128. How many times: 4000
Dataset Total: Population. Current Day: 2109. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24375289. How many times: 4000
Dataset Total: Population. Current Day: 2110. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24322448. How many times: 4000
Dataset Total: Population. Current Day: 2111. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24331434. How many times: 4000
Dataset Total: Population. Current Day: 2112. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24133115. How many times: 4000
Dataset Total: Population. Current Day: 2113. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24036789. How many times: 4000
Dataset Total: Population. Current Day: 2114. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24062197. How many times: 4000
Dataset Total: Population. Current Day: 2115. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24062234. How many times: 4000
Dataset Total: Population. Current Day: 2116. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24060789. How many times: 4000
Dataset Total: Population. Current Day: 2117. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24097503. How many times: 4000
Dataset Total: Population. Current Day: 2118. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24167391. How many times: 4000
Dataset Total: Population. Current Day: 2119. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24093126. How many times: 4000
Dataset Total: Population. Current Day: 2120. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24054347. How many times: 4000
Dataset Total: Population. Current Day: 2121. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24125120. How many times: 4000
Dataset Total: Population. Current Day: 2122. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24192373. How many times: 4000
Dataset Total: Population. Current Day: 2123. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24132725. How many times: 4000
Dataset Total: Population. Current Day: 2124. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24163951. How many times: 4000
Dataset Total: Population. Current Day: 2125. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24128711. How many times: 4000
Dataset Total: Population. Current Day: 2126. Min. OAS%: 43. Effort to achieve goal of: 298. Effort: 24136381. How many times: 4000
Recent CVM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 01:13:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 01:05:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 12:58:09 PM
- CEL-SCI Selects Ergomed as CRO as it Gears Up for Confirmatory FDA Registration Study of Multikine® in Head and Neck Cancer • Business Wire • 10/01/2024 10:00:00 AM
- CEL-SCI’s Multikine® Increased 5-Year Survival Rate to 82.6% in Locally Advanced Resectable Head & Neck Cancer Patients Who Were Deemed to be in the Treatment Group for Surgery and Radiation • Business Wire • 09/16/2024 11:30:00 AM
- CEL-SCI to Present New Data for Multikine® Head & Neck Cancer Immunotherapy at the European Society for Medical Oncology 2024 Congress • Business Wire • 09/10/2024 01:32:00 PM
- The UK’s Medicines & Healthcare Products Regulatory Agency Grants CEL-SCI a Pediatric Waiver, Bringing Multikine® One Step Closer to Future Marketing Clearance • Business Wire • 09/04/2024 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/30/2024 08:32:13 PM
- CEL-SCI Corporation Reports Third Quarter Fiscal 2024 Financial Results • Business Wire • 08/15/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:27:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 09:16:11 PM
- CEL-SCI Announces Closing of $10.8 Million Offering • Business Wire • 07/29/2024 08:05:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/29/2024 11:00:58 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 09:27:40 PM
- CEL-SCI Announces Pricing of $10.8 Million Offering • Business Wire • 07/26/2024 03:52:00 PM
- CEL-SCI’s Phase 3 Population Analysis for Upcoming Confirmatory Registration Study in Head & Neck Cancer Demonstrates Well Balanced Patient Population, Confidence in Clinical Results • Business Wire • 07/26/2024 12:23:00 PM
- CEL-SCI Appoints Robert Watson as Chairperson of the Board • Business Wire • 07/08/2024 01:15:00 PM
- CEL-SCI Presents Head & Neck Cancer Data at Iddst Annual Congress in Budapest: Risk of Death Cut in Half for Patients Treated With Multikine in the Target Population • Business Wire • 06/18/2024 12:00:00 PM
- Dr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical Advisor • Business Wire • 06/06/2024 11:00:00 AM
- CEL-SCI Corporation Reports Second Quarter Fiscal 2024 Financial Results • Business Wire • 05/16/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:17:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 01:04:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 05:07:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 01:19:04 PM
- CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer • Business Wire • 05/08/2024 01:00:00 PM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM